ANTI VIRAL PHARMACEUTICAL PREPARATION

Brand Owner (click to sort) Address Description
STRIDIST Bristol-Myers Squibb & Gilead Sciences 333 Lakeside Foster City CA 94404 Anti-viral pharmaceutical preparation for the treatment of HIV;
STRIKEBAC BRISTOL-MYERS SQUIBB COMPANY 430 E. 29th Street, 14th Floor New York NY 10016 ANTI-VIRAL PHARMACEUTICAL PREPARATION; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, STROKE, CANCER, INFLAMMATION AND INFLAMMATORY DISEASES, RESPIRATORY AND INFECTIOUS DISEASES AND AUTO-IMMUNE DISEASES;STRIKE BACK;
STRYVIST Bristol-Myers Squibb & Gilead Sciences 333 Lakeside Foster City CA 94404 Anti-viral pharmaceutical preparation for the treatment of HIV;
TRANSIMMUNE BRISTOL-MYERS SQUIBB COMPANY 430 E. 29th Street, 14th Floor New York NY 10016 anti-viral pharmaceutical preparation;
VIRAPDINE VIMRX Pharmaceuticals, Inc. 1177 High Ridge Road Stamford CT 06905 anti-viral pharmaceutical preparation;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Therapeutically effective anti-viral compositions, useful especially against respiratory diseases caused or mediated by respiratory syncytial virus (RSV) are disclosed, wherein said compositions comprise at least one anti-RSV antibody, including high affinity antibodies, and an additional anti-inflammatory agent, especially corticosteroids, as well as anti-inflammatory antibodies, especially anti-interleukin-6. Also disclosed are methods of using such compositions to treat and/or prevent respiratory diseases. Such compositions may optionally contain other non-antibody anti-viral agents.